References
- Alarcon-Segovia D. Mixed connective tissue disease. Appearance of antibodies to ribonucleo-protein following corticosteroid treatment. J Rheumatol 1979; 6: 694
- Bresnihan B., Bunn C., Smith M. L., Hughes G. R. V. Antiribonucleoprotein antibodies in connective tissue disease: estimation by counterimmunoelectrophoresis. Br Med J 1977; 1: 610
- Bresnihan B., Grigor R., Hughes G. R. V. Prospective analysis of antiribonucleoprotein antibodies in systemic lupus erythematosus. Ann Rheum Dis 1977; 36: 557
- Cohen A. S., Reynolds W. E., Franklin E. C., Kulka J. P., Ropes M. W., Sulman L. F., Wallace S. L. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971; 21: 643
- Dorsch C. A., Feinglass E. J., Stevens M. B. Clinical significance of antibodies to Extract-able Nuclear Antigen (ENA) in systemic lupus erythematosus. Arthritis Rheum 1977; 20: 114
- Grennan D. M., Bunn C., Hughes G. R. V., Buckanan W. W., Dick W. C. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups. Ann Rheum Dis 1977; 36: 442
- Griffiths I. D., Munford P., Maini R. N., Scott J. T. Clinical significance of antibodies to Extractable Nuclear Antigens (ENA). Ann Rheum Dis 1977; 36: 479
- Grigor R., Edmonds J., Lewkonia R., Bresnihan B., Hughes G. R. V. Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 1978; 37: 121
- Hamburger M., Hodes S., Barland P. The incidence and clinical significance of antibodies to Extractable Nuclear Antigens. Am J Med Sci 1977; 273: 21
- Hochberg M. C., Dorsch C. A., Feinglass E. J., Stevens M. B. Survivorship in systemic lupus erythematosus. Arthritis Rheum 1981; 24: 54
- Holian J., Grifiths J. D., Glass D. N., Maini R. N., Scott J. T. Human anti-DNA antibodies: reference standards for diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 1975; 34: 438
- Keiser H. D., Weinstein J. The detection and identification of antibodies to saline Extractable Nuclear Antigens by counterimmunoelectrophoresis. Arthritis Rheum 1980; 23: 1026
- Kurata N., Tan E. M. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976; 19: 574
- Parker M. D. Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease. J Lab Clin Med 1973; 82: 769
- Reichlin M. Mixed connective tissue disease. Modern Topics in Rheumatology, G. R. V. Hughes. Yearbook Medical Publishers, Great Britain 1976
- Reichlin M., Mattioli M. Correlation of precipitin reaction to an RNA protein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med 1972; 286: 908
- Sharp G. C., Irwin W. S., May C. M., Holman H. R., McDufie F. C., Hess E. V., Schmid F. R. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease, systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976; 295: 1149
- Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease. An apparently distinct rheumatic disease syndrome associated with a specific antibody to an Extractable Nuclear Antigen (ENA). Am J Med 1972; 52: 148
- Synkowski D. R., Mogevero H. S., Provost T. T. Lupus erythematosus. Laboratory testing and clinical subsets in the evaluation of patients. Med Clin North 1980; 64: 921